Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001086364-12-000615
Filing Date
2012-02-09
Accepted
2012-02-09 13:15:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 qiagen.nv.reg.shs..txt SC 13G 11511
  Complete submission text file 0001086364-12-000615.txt   13198
Mailing Address SPOORSTRAAT 50 KJ VENLO P7 5911
Business Address SPOORSTRAAT 50 KJ VENLO P7 5911 31-77-320-8400
QIAGEN NV (Subject) CIK: 0001015820 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-54659 | Film No.: 12585913
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 55 EAST 52ND STREET NEW YORK NY 10055
Business Address 55 EAST 52ND STREET NEW YORK NY 10055 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

EIN.: 320174431 | State of Incorp.: DE | Fiscal Year End: 0226
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies